Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

AZ-Targacept depression candidate moves into phase IIb

February 9, 2011 Research and Development AZ, AstraZeneca, TC-5214, Targacept, depression, major depressive disorder

AstraZeneca and Targacept have begun a phase IIb trial of TC-5214 as a ‘switch’ monotherapy for patients with depression. The …
News
AstraZeneca's Iressa (gefitinib)

AZ and Pfizer support personalised medicine database

February 8, 2011 Research and Development AZ, AstraZeneca, Cancer Research UK, Iressa, Pfizer, crizotinib, gefitinib, personalised medicine

AstraZeneca and Pfizer have teamed up with leading charity Cancer Research UK to help develop its stratified medicines programme. Stratified …
News
Pfizer research Sandwich, Kent

Pressure mounts on Pfizer and government over UK R&D closure

February 7, 2011 Research and Development Kent, Pfizer, Sandwich, Science and Technology Select Committee

The political fallout over Pfizer’s decision to close its Kent R&D base continues apace, with the House of Commons to …
News

Late-stage blow to AstraZeneca’s prostate cancer drug

February 7, 2011 Research and Development AstraZeneca, Cancer, prostate cancer, zibotentan

A late-stage trial of AstraZeneca’s oral prostate cancer drug zibotentan has been halted after it failed to meet its primary …
News

Bayer’s regorafenib gains orphan status for GIST

February 4, 2011 Research and Development, Sales and Marketing Bayer, FDA, GIST, gastrointestinal stromal tumours, orphan drug, regorafenib

Bayer’s investigational compound regorafenib has been granted orphan drug status for the treatment of patients with gastrointestinal stromal tumours (GIST) …
News
Pfizer research Sandwich, Kent

ABPI backs UK science after Pfizer’s R&D exit

February 4, 2011 Research and Development Kent, Pfizer, Sandwich

The ABPI has defended the UK’s research environment against mounting criticism following Pfizer’s decision to close its Kent research base. …
News

Working Life: Merck Sharp & Dohme medical director Paul Robinson

February 4, 2011 Business Services, Research and Development MSD, Paul Robinson, Working Life, careers, merck sharp and dohme, recruitment

Paul Robinson, medical director at Merck Sharp & Dohme, looks at how his field is changing, the most enjoyable things …
News

Five capabilities of centered leadership

February 3, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Caroline Webb, Joanna Barsh, Josephine Mogelof, McKinsey & Company, leadership

The business environment has become more demanding: the global financial crisis and subsequent economic downturn have ratcheted up the pressure …
Feature

Pfizer appoints Dr Yvonne Greenstreet to specialty care business

February 3, 2011 Research and Development Dr Yvonne Greenstreet, Pfizer, appointment, specialty care

Dr Yvonne Greenstreet has joined Pfizer to head up medicines development for its Specialty Care business unit. She moves to …
Appointment
Roche Severin Schwann

Roche weathers tough year and looks to pipeline for 2011

February 3, 2011 Research and Development, Sales and Marketing 2010 pharma results, BRAF protein, GDC-0449, RG3616, RG7204, Roche, avastin, pertuzumab

Roche is looking to its innovative late-stage pipeline to help it get back on track for the next financial year …
News

Blood clot fears halt cancer trial enrolment

February 3, 2011 Research and Development BMS, Bristol-Myers Squibb, Eli Lilly, NSCLC, lilly, necitumumab, non small cell lung cancer, non-small cell lung cancer

Lilly and BMS have stopped enrolment in a phase III trial of necitumumab, a new treatment for non-small cell lung …
News
Sandwich R&D

Government seeks to salvage Pfizer site

February 2, 2011 Research and Development Pfizer, Sandwich

Science minister David Willetts says the government will do all it can to maintain pharma research in Kent, after Pfizer …
News

Leading universities sound alarm over UK research

February 2, 2011 Research and Development Jobs, Pfizer, Sandwich, universities

Cuts to government funding for research in universities have been condemned by the UK’s top centres of learning. The government …
News
Pfizer's R&D site in Sandwich, Kent

Pfizer to close UK R&D site

February 1, 2011 Research and Development Kent, Pfizer, R&D, Sandwich, closure

Pfizer has announced that it is to close its UK research site at Sandwich in Kent, with the loss of …
News

UK hails high uptake of cervical cancer vaccine

January 31, 2011 Research and Development Cervarix, HPV

The NHS campaign to vaccinate girls against the future risk of developing cervical cancer has been a success, according to …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026